Suppliers / Jiangxi Kvvit Pharmaceutical

Jiangxi Kvvit Pharmaceutical

China Updated 9 July 2026

Jiangxi Kvvit Pharmaceutical is an API and finished-dose manufacturer based in China. It holds one active US drug master file.

1
active US DMFs
0
valid CEPs
1
registered plants 1 with an FDA FEI number
1
filings across 1 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026.

Registered plants

Site FDA FEI
China, China 3037146422

What they file, and where

Molecule Regulators Docs
Enzalutamide US FDA 1

Also appears on these molecule pages

Olaparib finished dose Enzalutamide API

Filings and GMP by regulator

Regulator Filings GMP certificates
MINSA (CR) 1 None

Comparing suppliers?

Choose your molecules and target markets. Jiangxi Kvvit Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability